1.38 USD
↗ 0.03 (2.22%)AT CLOSE (11:59 AM EDT)
iBio, Inc. Common Stock
IBIONASDAQ • USD
1.41
↗ 0.03 (2.10%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
1.41
↗ 0.03 (2.10%)
Market: CLOSED
IBIO is currently priced at $1.38. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place IBIO at a fair price relative to peers.
Technical & fundamental data as of Jul 17, 2026.
Open?$1.34
High?$1.44
Low?$1.31
Prev. Close?$1.35
Volume?603.1K
Avg. Volume?1.0M
VWAP?$1.39
Rel. Volume?0.58x
Bid / Ask
Bid?$1.12 × 100
Ask?$1.66 × 100
Spread?$0.54
Midpoint?$1.39
Valuation & Ratios
Market Cap?67.1M
Shares Out?49.7M
Float?31.5M
Float %?91.3%
P/E Ratio?N/A
P/B Ratio?0.86
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Themes
Address
600 MADISON AVENUE, SUITE 1601
NEW YORK, NY 10022-1737
Phone: 302 355-0650
NEW YORK, NY 10022-1737
Phone: 302 355-0650
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?65
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.69Distress
Confidence?46%Low
Short InterestHigh
Short % of Float?14.89%High
Short Interest?4.7M
Days to Cover?5.1
Free Float31.5M
Avg Daily Volume925.0K
Settlement Date2026-06-30
Financial Health
Current Ratio?11.88Strong
Quick Ratio?11.88Strong
Cash Ratio?7.32Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?0.86CHEAP▾
Peers100
S&P97
P/S?223.55HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.0CHEAP▾
S&P97
EV/Sales?64.78HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-24.1%WEAK▾
S&P7
ROA?-21.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-22181000
Enterprise Value?$19.4M
Fundamentals ratios updated end of day